loadpatents
Patent applications and USPTO patent grants for Swinamer; Alan David.The latest application filed is for "pyridinyl compounds useful as intermediates".
Patent | Date |
---|---|
CCR10 antagonists Grant 8,299,123 - Dey , et al. October 30, 2 | 2012-10-30 |
Indazole compounds as CCR1 receptor antagonists Grant 8,263,597 - Kuzmich , et al. September 11, 2 | 2012-09-11 |
Pyridinyl Compounds Useful As Intermediates App 20120136158 - COOK; Brian Nicholas ;   et al. | 2012-05-31 |
Azaindazole Compounds As CCR1 Receptor Antagonists App 20120035370 - COOK; Brian Nicholas ;   et al. | 2012-02-09 |
Indazole Compounds As CCR1 Receptor Antagonists App 20110294808 - KUZMICH; Daniel ;   et al. | 2011-12-01 |
Azaindazole compounds as CCR1 receptor antagonists Grant 8,063,065 - Cook , et al. November 22, 2 | 2011-11-22 |
Pyrazole Compounds As CCR1 Antagonists App 20110230521 - Cook; Brian Nicholas ;   et al. | 2011-09-22 |
Indazole compounds as CCR1 receptor antagonists Grant 8,008,327 - DiSalvo , et al. August 30, 2 | 2011-08-30 |
Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors App 20110118262 - Bentzien; Joerg Martin ;   et al. | 2011-05-19 |
Azaindazole Compounds As CCR1 Receptor Antagonists App 20110086846 - COOK; Brian Nicholas ;   et al. | 2011-04-14 |
Ccr10 Antagonists App 20110039851 - Dey; Kaka ;   et al. | 2011-02-17 |
Indazole Compounds As CCR1 Receptor Antagonists App 20110034512 - Disalvo; Darren ;   et al. | 2011-02-10 |
Azaindazole compounds as CCR1 receptor antagonists Grant 7,879,873 - Cook , et al. February 1, 2 | 2011-02-01 |
Azaindazole Compounds As CCR1 Receptor Antagonists App 20100093724 - COOK; Brian Nicholas ;   et al. | 2010-04-15 |
Cytokine inhibitors Grant 7,569,568 - Cogan , et al. August 4, 2 | 2009-08-04 |
Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases Grant 7,550,461 - Gao , et al. June 23, 2 | 2009-06-23 |
Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same App 20090111791 - De Lombaert; Stephane ;   et al. | 2009-04-30 |
Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors App 20090099184 - Delombaert; Stephane ;   et al. | 2009-04-16 |
Anti-cytokine heterocyclic compounds Grant 7,514,458 - Cogan , et al. April 7, 2 | 2009-04-07 |
Anti-cytokine heterocyclic compounds Grant 7,485,657 - Cogan , et al. February 3, 2 | 2009-02-03 |
Anti-Cytokine Heterocyclic Compounds App 20070142371 - Cogan; Derek ;   et al. | 2007-06-21 |
Anti-cytokine heterocyclic compounds Grant 7,214,802 - Cogan , et al. May 8, 2 | 2007-05-08 |
Cytokine Inhibitors App 20070032492 - Cogan; Derek A. ;   et al. | 2007-02-08 |
Cytokine inhibitors Grant 7,166,628 - Cogan , et al. January 23, 2 | 2007-01-23 |
Anti-cytokine heterocyclic compounds App 20060079519 - Cogan; Derek ;   et al. | 2006-04-13 |
Anti-cytokine heterocyclic compounds App 20050256113 - Cogan, Derek ;   et al. | 2005-11-17 |
Cytokine inhibitors App 20040102492 - Cogan, Derek A. ;   et al. | 2004-05-27 |
Compounds useful in treating cytokine mediated diseases App 20030225053 - Gao, Donghong Amy ;   et al. | 2003-12-04 |
Aromatic heterocyclic compounds as antiinflammatory agents Grant 6,525,046 - Cirillo , et al. February 25, 2 | 2003-02-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.